Therapeutic applications of CRISPR-Cas9 gene editing
CRISPR-Cas9 is a gene editing tool used extensively in biological research that is now making its way into clinical therapies. With the first CRISPR therapy obtaining approval by the United States’ Food and Drug Administration (FDA) in late 2023, we look at clinical trials of emerging therapies invo...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2025-12-01
|
| Serie: | Frontiers in Genome Editing |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/fgeed.2025.1724291/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|